Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
Logo
  • About Us
    • Key Advisors
    • Leadership Team
    • Board of Directors
    • Vision / Mission
  • Products & Services
  • Therapeutic Pipeline
  • Biosort AI
  • Media
    • News
    • Videos/Podcasts
    • Key Industry Deals
    • Blog
  • Contact Us
    • Contact
  • White Paper: Industrial Scale Microbiome Mining...

Follow Us linked In
2024 November
  • Home
  • Archive for November, 2024
A conversation with a genius lightbulb

Ross Youngs “A conversation with a genius”

  • November 27 2024

By Ross Youngs, November 27, 2024 “A conversation with a genius” Key points: The bottleneck in drug discovery suggests we need 1,000,000,000,000,000,000,000,000,000 years or more. Even with generous assumptions and the full force of global computing power, creating and testing all possible drug-like molecules within a reasonable timeframe remains a distant prospect. However, this thought experiment

Continue Reading

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact

  • November 12 2024

Novartis pays Schrödinger $150M, bets billions on the back end to form drug discovery pact (November 12, 2024) by Nick Paul Taylor. ovartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs and identify

Continue Reading

RSS Industry News

  • The human gut mycobiome in the context of primate evolution October 2 2025
  • How nutrient starvation impacts the gut microbiome September 30 2025
  • Impact of shared spaces and daily routines on shared microbiome September 29 2025
  • Elucidating the role of group A Streptococcus genomics and pharyngeal microbiota in acute paediatric pharyngitis September 29 2025
  • Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities September 29 2025
  • A newborn derived monoclonal IgM antibody selectively modulates microbial metabolism in the gut September 29 2025
  • Author Correction: Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development September 29 2025
  • Maternal gut microbiome in early pregnancy: predictor of preterm birth? September 29 2025
  • Complex carbohydrate utilization by gut bacteria modulates host food consumption September 25 2025
  • Association between exacerbation history and airway bacterial community assessed by extended bacterial culture and sequencing approaches in stable COPD September 25 2025
Quick Link
  • Products & Services
  • Blog
  • Contact
Recent Posts
  • Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
  • Roche to buy 89bio in deal worth up to $3.5B, picking up MASH drug
  • Servier supercharges neuro pipeline with $450M deal for Fragile X syndrome candidate
Sign up for our newsletter
Loading
Biosortia Microbiomics © 2024. All Rights Reserved